Early identification and treatment of Alzheimer's disease: Social and fiscal outcomes
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disease that places substantial burdens on those who provide support for family members with declining cognitive and functional abilities. Many AD patients eventually require formal long‐term care services because of the absence, exhaustion, or inability of family members to provide care. The costs of long‐term care, and especially nursing home care, often deplete private financial resources, placing a substantial burden on state Medicaid programs. Current evidence suggests that pharmacological treatments and caregiver interventions can delay entry into nursing homes and potentially reduce Medicaid costs. However, these cost savings are not being realized because many patients with AD are either not diagnosed or diagnosed at late stages of the disease, and have no access to Medicare‐funded caregiver support programs. Methods and Results: A Monte Carlo cost‐benefit analysis, based on estimates of parameters available in the medical literature, suggests that the early identification and treatment of AD have the potential to result in large, positive net social benefits as well as positive net savings for states and the federal government. Conclusions: These findings indicate that the early diagnosis and treatment of AD are not only socially desirable in terms of increasing economic efficiency, but also fiscally attractive from both state and federal perspectives. These findings also suggest that failure to fund effective caregiver interventions may be fiscally unsound.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide to Clinical Preventive Services
Wesley Allen, T. (1991) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1991-900515 · Cited by 2,129
Cost-Benefit Analysis: Concepts and Practice
Boardman, A. E., Greenberg, D. H., Vining, A. R., & Weimer, D. L. (1996) · Cited by 1,920
Self-citationAlzheimer’s Dementia: Dilemmas in Clinical Research
(1985) · Humana Press eBooks · doi:10.1007/978-1-4612-5174-3 · Cited by 981
Callahan, C. M., Boustani, M. A., Unverzagt, F. W., Austrom, M. G., Damush, T. M., Perkins, A. J., Fultz, B. A., Hui, S. L., Counsell, S. R., & Hendrie, H. C. (2006) · JAMA · doi:10.1001/jama.295.18.2148 · Cited by 798
Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease
Mittelman, M. S., Haley, W. E., Clay, O. J., & Roth, D. L. (2006) · Neurology · doi:10.1212/01.wnl.0000242727.81172.91 · Cited by 602 · cited 10×
“, an MMSE score of 28, and when drug therapy was combined with a caregiver intervention program [7].”
BackgroundMethodInfluentialCovinsky, K. E., Newcomer, R., Fox, P., Wood, J., Sands, L., Dane, K., & Yaffe, K. (2003) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2003.30103.x · Cited by 567
The Detection of Dementia in the Primary Care Setting
Valcour, V. G., Masaki, K. H., Curb, J. D., & Blanchette, P. L. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.19.2964 · Cited by 498
Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050
Hebert, L. E., Beckett, L. A., Scherr, P. A., & Evans, D. A. (2001) · Alzheimer Disease and Associated Disorders · doi:10.1097/00002093-200110000-00002 · Cited by 467 · cited 1×
“The costs of long-term care, and especially nursing home care, often deplete private financial resources, placing a substantial burden on state Medicaid programs.”
BackgroundMittelman, M. S., Roth, D. L., Coon, D. W., & Haley, W. E. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.850 · Cited by 383
United States life tables, 2003.
Arias, E. (2006) · PubMed · Cited by 375
Implementing a screening and diagnosis program for dementia in primary care
Boustani, M., Callahan, C. M., Unverzagt, F. W., Austrom, M. G., Perkins, A. J., Fultz, B. A., Hui, S. L., & Hendrie, H. C. (2005) · Journal of General Internal Medicine · doi:10.1007/s11606-005-0103-7 · Cited by 374 · cited 3×
“To answer this question, we estimated the results and costs of a dementia-diagnosis protocol, using the findings of Boustani et al [15].”
MethodInfluentialDiagnosing Dementia: Perspectives of Primary Care Physicians
Boise, L., Camicioli, R., Morgan, D. L., Rose, J. H., & Congleton, L. (1999) · The Gerontologist · doi:10.1093/geront/39.4.457 · Cited by 328
Cost-effectiveness of Treatments for Major Depression in Primary Care Practice
Lave, J. R., Frank, R. G., Schulberg, H. C., & Kamlet, M. S. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.7.645 · Cited by 306
Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer’s disease
Neumann, P. J., Hermann, R. C., Kuntz, K. M., Araki, S. S., Duff, S. B., Leon, J., Berenbaum, P. A., Goldman, P. A., Williams, L. W., & Weinstein, M. C. (1999) · Neurology · doi:10.1212/wnl.52.6.1138 · Cited by 244
Carpenter, B. D., Xiong, C., Porensky, E. K., Lee, M. M., Brown, P. J., Coats, M., Johnson, D., & Morris, J. C. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01600.x · Cited by 194
Survival following dementia onset: Alzheimer's disease and vascular dementia
Fitzpatrick, A. L., Kuller, L. H., Lopez, O. L., Kawas, C. H., & Jagust, W. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.022 · Cited by 177
Disease‐modifying therapies in Alzheimer's disease
Salloway, S., Mintzer, J., Weiner, M. F., & Cummings, J. L. (2008) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.10.001 · Cited by 161
Bell, C. M., Araki, S. S., & Neumann, P. J. (2001) · Alzheimer Disease and Associated Disorders · doi:10.1097/00002093-200107000-00004 · Cited by 156
Dementia Screening in Primary Care: Is It Time?
Brayne, C., Fox, C., & Boustani, M. A. (2007) · JAMA · doi:10.1001/jama.298.20.2409 · Cited by 141
Dementia Assessment in Primary Care: Results From a Study in Three Managed Care Systems
Boise, L., Neal, M. B., & Kaye, J. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.6.m621 · Cited by 134
Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic
Matthews, H. P., Korbey, J., Wilkinson, D. G., & Rowden, J. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/1099-1166(200008)15:8<713::aid-gps187>3.0.co;2-i · Cited by 112
Pham, S. V., & Draugalis, J. R. (1993) · Pharmacy World & Science · doi:10.1007/bf01874083 · Cited by 109
Lopez, O. L., Becker, J. T., Saxton, J., Sweet, R. A., Klunk, W., & DeKosky, S. T. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53015.x · Cited by 106
Soo Borson, B., Scanlan, J. M., Hummel, J., Gibbs, K., Lessig, M. C., & Zuhr, E. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0202-8 · Cited by 105
How Much Do Persons with Alzheimer's Disease Cost Medicare?
Taylor, D. H., & Sloan, F. A. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04721.x · Cited by 99
Cost of Illness of Alzheimer's Disease: How Useful Are Current Estimates?
Bloom, B. S., de Pouvourville, N., & Straus, W. L. (2003) · The Gerontologist · doi:10.1093/geront/43.2.158 · Cited by 93
Small, G. W., Kaufer, D., Mendiondo, M. S., Quarg, P., & Spiegel, R. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00524.x · Cited by 91
Bullock, R., & Dengiz, A. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00562.x · Cited by 87
Treatment of Dementia in Community‐Dwelling and Institutionalized Medicare Beneficiaries
Gruber‐Baldini, A. L., Stuart, B., Zuckerman, I. H., Simoni‐Wastila, L., & Miller, R. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01387.x · Cited by 77
Underrecognition of Cognitive Impairment in Assisted Living Facilities
Magsi, H., & Malloy, T. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53117.x · Cited by 71
Potential Savings in the Cost of Caring for Alzheimer??s Disease: Treatment with Rivastigmine
Hauber, B., Gnanasakthy, A., Snyder, E. H., BALA, M. M., Richter, A., & Mauskopf, J. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017040-00005 · Cited by 71
Treatment Guidelines for Alzheimer's Disease: Redefining Perceptions in Primary Care
Geldmacher, D. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0205 · Cited by 65
Effects of the Medicare Alzheimer's Disease Demonstration on the use of community-based services.
Newcomer, R., Spitalny, M., Fox, P. J., & Yordi, C. (1999) · Europe PMC (PubMed Central) · Cited by 61
Caregivers’ preferences for the treatment of patients with Alzheimer’s disease
Karlawish, J. H. T., Klocinski, J. L., Merz, J., Clark, C. M., & Asch, D. A. (2000) · Neurology · doi:10.1212/wnl.55.7.1008 · Cited by 60
Do cholinergic therapies have disease‐modifying effects in Alzheimer's disease?
Sabbagh, M. N., Farlow, M. R., Relkin, N. R., & Beach, T. G. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.02.001 · Cited by 55
Is donepezil therapy associated with reduced mortality in nursing home residents with dementia?
Gasper, M. C., Ott, B. R., & Lapane, K. L. (2005) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2005.02.001 · Cited by 51
The Effect of a Memory Screening Program on the Early Diagnosis of Alzheimer Disease
Barker, W., Luis, C. A., Harwood, D. G., Loewenstein, D., Bravo, M., Ownby, R., & Duara, R. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000155380.63231.68 · Cited by 43
Dale, W., Hougham, G. W., Hill, E. K., & Sachs, G. A. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00852.x · Cited by 34
Pousa, S. L., Garre‐Olmo, J., Franch, J. V., Estrada, A. T., Cors, O. S., Nierga, I. P., & Gelada-Batlle, E. (2006) · Age and Ageing · doi:10.1093/ageing/afj083 · Cited by 31
Belle, S. H., Burgio, L., Burns, R., Coon, D., Czaja, S. J., Gallagher-Thompson, D., Gitlin, L. N., Klinger, J., Koepke, K. M., Lee, C. C., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00005 · Cited by 23
Dale, W., Hemmerich, J. A., Hill, E. K., Hougham, G. W., & Sachs, G. A. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318161103c · Cited by 20
Cited by
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941
“The benefits of earlier diagnosis are now quite clearly established [57], including the societal benefit that investing in earlier diagnosis and intervention may lead to net savings from delayed institutionalization [58–60].”
BackgroundDementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
Braun, M., Tupper, D., Kaufmann, P., McCrea, M., Postal, K., Westerveld, M., Wills, K., & Deer, T. (2011) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3182351289 · Cited by 1,056
Timely Diagnosis for Alzheimer’s Disease: A Literature Review on Benefits and Challenges
Dubois, B., Padovani, A., Scheltens, P., Rossi, A., & Dell’Agnello, G. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150692 · Cited by 562
Metadata
- Authors
- Weimer, D. L., & Sager, M. A.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2009-04-13
- Volume
- 5
- Issue
- 3
- Pages
- 215-226
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2141309434
- Cited by
- 257
- References
- 41
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.